INFOBIRD CO LTD (IFBD)

KYG477243003 - Common Stock

3.3  +0.66 (+25%)

After market: 3.13 -0.17 (-5.15%)

Fundamental Rating

3

IFBD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 279 industry peers in the Software industry. While IFBD has a great health rating, there are worries on its profitability. IFBD has a expensive valuation and it also scores bad on growth.



2

1. Profitability

1.1 Basic Checks

IFBD had negative earnings in the past year.
In the past year IFBD has reported a negative cash flow from operations.
In multiple years IFBD reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: IFBD reported negative operating cash flow in multiple years.

1.2 Ratios

IFBD's Return On Assets of -4.47% is in line compared to the rest of the industry. IFBD outperforms 49.10% of its industry peers.
The Return On Equity of IFBD (-4.47%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -4.47%
ROE -4.47%
ROIC N/A
ROA(3y)-48.32%
ROA(5y)-15.28%
ROE(3y)-109.59%
ROE(5y)-27.3%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

IFBD has a Gross Margin of 55.26%. This is in the lower half of the industry: IFBD underperforms 65.59% of its industry peers.
In the last couple of years the Gross Margin of IFBD has grown nicely.
The Profit Margin and Operating Margin are not available for IFBD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.26%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.47%
GM growth 5Y1.82%

8

2. Health

2.1 Basic Checks

IFBD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IFBD has more shares outstanding
Compared to 5 years ago, IFBD has more shares outstanding
IFBD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 49.37 indicates that IFBD is not in any danger for bankruptcy at the moment.
IFBD has a better Altman-Z score (49.37) than 97.13% of its industry peers.
IFBD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 49.37
ROIC/WACCN/A
WACC10.62%

2.3 Liquidity

IFBD has a Current Ratio of 86.79. This indicates that IFBD is financially healthy and has no problem in meeting its short term obligations.
IFBD has a better Current ratio (86.79) than 100.00% of its industry peers.
IFBD has a Quick Ratio of 86.79. This indicates that IFBD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 86.79, IFBD belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 86.79
Quick Ratio 86.79

0

3. Growth

3.1 Past

IFBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 92.70%, which is quite impressive.
Looking at the last year, IFBD shows a very negative growth in Revenue. The Revenue has decreased by -94.91% in the last year.
IFBD shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -56.88% yearly.
EPS 1Y (TTM)92.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.28%
Revenue 1Y (TTM)-94.91%
Revenue growth 3Y-73.19%
Revenue growth 5Y-56.88%
Sales Q2Q%-90.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IFBD. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

IFBD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INFOBIRD CO LTD

NASDAQ:IFBD (11/29/2024, 3:38:02 PM)

After market: 3.13 -0.17 (-5.15%)

3.3

+0.66 (+25%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap6.57M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.47%
ROE -4.47%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 55.26%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 86.79
Quick Ratio 86.79
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)92.7%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-94.91%
Revenue growth 3Y-73.19%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y